Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
批准号:
10581946
负责人:
ROSALIND A. SEGAL
金额:
$22.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-15 至 2024-12-31
关键词:
AccelerationAffectAlternative SplicingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAntigensAreaAxonAxonal TransportBindingCause of DeathCell NucleusCellsCentral Nervous SystemCytoplasmCytoplasmic GranulesDNA RepairDataDefectDiseaseEarly InterventionEarly identificationEventFutureGlutamineHumanImageImpairmentInterruptionInterventionKinesinLeadLearningLiquid substanceMeasuresMessenger RNAMethodsModelingMolecularMolecular ConformationMotorMotor NeuronsMutationNatureNerve DegenerationNeurodegenerative DisordersNeuronsNuclearOnset of illnessPathogenesisPathogenicityPathologicPathologyPersonsPharmacologic SubstancePhasePhysical condensationPlayProlineProtein SplicingRNARNA SplicingRNA TransportRNA-Binding ProteinsResearchRoleT-LymphocyteTauopathiesTestingTherapeuticTimeTranslationsWorkaxonopathyaxoplasmcell typecombatcytotoxicgenetic approachhyperphosphorylated tauinduced pluripotent stem cellinnovationloss of functionmRNA Exportmutantneuronal cell bodynucleocytoplasmic transportpharmacologicpreventprogramsprotein aggregationprotein functionstress granuletau Proteinstau aggregationtau mutationtau-1
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract:
Alzheimer’s Disease and Alzheimer’s Disease Related Disorders belong to a devastating class of
neurodegenerative diseases called tauopathies, marked by pathologic aggregation of hyper-phosphorylated tau
protein (phospho-tau)1. An early event in the onset of tauopathies is the formation of pathologic-stress granules
(p-SGs); cytotoxic biomolecular condensates (BMCs) consisting of toxic phospho-tau oligomers and RNA-
binding proteins (RBPs) T-Cell Intracellular Antigen 1 (TIA1) and Splicing Factor Proline and Glutamine Rich
(SFPQ) that accumulate in the cytoplasm of neural cells2–4,8. While it is evident that p-SGs play an important role
in the pathogenesis of tauopathy2,3,5,75, it is unknown how they form and how they impact homeostatic functions
of the proteins they sequester. Defects in axonal transport have been established as an early event
accompanying phospho-tau pathology, with conformational changes in pathologic tau leading to inhibition of
anterograde axonal transport through kinesin motors32–34. Since several SG associated RBPs, including SFPQ,
rely on kinesins to transport mRNAs9,10, we propose that early deficits in axonal transport lead to buildup of
transport RBPs in the cytoplasm, where they aggregate, contributing to formation of p-SGs. Once sequestered
in p-SGs, we predict that RBP homeostatic functions are disrupted, enhancing tau-mediated neurodegeneration.
To test our model, we will use innovative methods for interrupting axonal transport in WT and P301S MAPT
mutant human induced cortical neurons (iCNs) and motor neurons (iMNs). We will evaluate whether disruption
of particular transport programs accelerates formation of the BMCs that are the p-SGs. To determine whether
sequestration of RBP SFPQ in p-SGs disrupts critical homeostatic functions in the nucleus and/or the axons of
cortical and motor neurons, we will again use WT and P301S MAPT mutant human induced cortical neurons
(iCNs) and motor neurons (iMNs) and interrogate the multiple essential functions of SFPQ57, including DNA
repair, nuclear mRNA export, and axonal mRNA transport. Results from these studies will identify early targets
for pharmacologic intervention in the pathogenesis of tauopathy and identify essential differences in the onset of
disease in different cells types of the central nervous system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
-
批准号:9251786
-
项目类别:
-
资助金额:$57.75万
-
财政年份:2016
-
负责人:ROSALIND A. SEGAL
-
依托单位:
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
-
批准号:9896777
-
项目类别:
-
资助金额:$57.75万
-
财政年份:2016
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Axonal transport and chemotherapy induced peripheral neuropathy
-
批准号:10649524
-
项目类别:
-
资助金额:$57.85万
-
财政年份:2016
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Axonal transport and chemotherapy induced peripheral neuropathy
-
批准号:10522882
-
项目类别:
-
资助金额:$59.03万
-
财政年份:2016
-
负责人:ROSALIND A. SEGAL
-
依托单位:
2013 Neurotrophic Factors GRC
-
批准号:8524238
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2013
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Therapeutic Opportunities for Pediatric Astrocytoma
-
批准号:8019642
-
项目类别:
-
资助金额:$166.01万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Therapeutic Opportunities for Pediatric Astrocytoma
-
批准号:8450180
-
项目类别:
-
资助金额:$149.7万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Therapeutic Opportunities for Pediatric Astrocytoma
-
批准号:8627572
-
项目类别:
-
资助金额:$154.0万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Therapeutic Opportunities for Pediatric Astrocytoma
-
批准号:8230535
-
项目类别:
-
资助金额:$163.34万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Specialized Niches for Pediatric Astrocytoma Cells
-
批准号:8044511
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
Administrative Core
-
批准号:8044515
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
2011 Neurotrophic Factors Gordon Research Conference
-
批准号:8118689
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2011
-
负责人:ROSALIND A. SEGAL
-
依托单位:
New approaches to local translation: spaceSTAMP of proteins synthesized in axons
-
批准号:8240550
-
项目类别:
-
资助金额:$41.91万
-
财政年份:2010
-
负责人:ROSALIND A. SEGAL
-
依托单位:
New approaches to local translation: spaceSTAMP of proteins synthesized in axons
-
批准号:7993398
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2010
-
负责人:ROSALIND A. SEGAL
-
依托单位:
New approaches to local translation: spaceSTAMP of proteins synthesized in axons
-
批准号:8443436
-
项目类别:
-
资助金额:$40.19万
-
财政年份:2010
-
负责人:ROSALIND A. SEGAL
-
依托单位:
New approaches to local translation: spaceSTAMP of proteins synthesized in axons
-
批准号:8082715
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2010
-
负责人:ROSALIND A. SEGAL
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7195867
-
项目类别:
-
资助金额:$85.46万
-
财政年份:2006
-
负责人:ROSALIND A. SEGAL
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7911829
-
项目类别:
-
资助金额:$85.5万
-
财政年份:2006
-
负责人:ROSALIND A. SEGAL
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7292769
-
项目类别:
-
资助金额:$85.5万
-
财政年份:2006
-
负责人:ROSALIND A. SEGAL
-
依托单位:
NIH Director's Pioneer Award
-
批准号:7672429
-
项目类别:
-
资助金额:$85.5万
-
财政年份:2006
-
负责人:ROSALIND A. SEGAL
-
依托单位:
海外基金